Cargando…
The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas
Our study evaluated the role of the T2–fluid-attenuated inversion recovery (FLAIR) mismatch sign in detecting isocitrate dehydrogenase (IDH) mutations based on a mixed sample of 24 patients with low- and high- grade gliomas. The association between the two was realized using univariate and multivari...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699466/ https://www.ncbi.nlm.nih.gov/pubmed/33228171 http://dx.doi.org/10.3390/brainsci10110874 |
_version_ | 1783616054639984640 |
---|---|
author | Kapsalaki, Eftychia Z. Brotis, Alexandros G. Tsikrika, Alexandra Tzerefos, Christos Paschalis, Thanos Dardiotis, Efthymios Fountas, Konstantinos N. |
author_facet | Kapsalaki, Eftychia Z. Brotis, Alexandros G. Tsikrika, Alexandra Tzerefos, Christos Paschalis, Thanos Dardiotis, Efthymios Fountas, Konstantinos N. |
author_sort | Kapsalaki, Eftychia Z. |
collection | PubMed |
description | Our study evaluated the role of the T2–fluid-attenuated inversion recovery (FLAIR) mismatch sign in detecting isocitrate dehydrogenase (IDH) mutations based on a mixed sample of 24 patients with low- and high- grade gliomas. The association between the two was realized using univariate and multivariate logistic regression analysis. There was a substantial agreement between the two raters for the detection of the T2–FLAIR mismatch sign (Cohen’s kappa coefficient was 0.647). The T2–FLAIR mismatch sign when co-registered with the degree of tumor homogeneity were significant predictors of the IDH status (OR 29.642; 95% CI 1.73–509.15, p = 0.019). The probability of being IDH mutant in the presence of T2–FLAIR mismatch sign was as high as 92.9% (95% CI 63–99%). The sensitivity and specificity of T2–FLAIR mismatch sign in the detection of the IDH mutation was 88.9% and 86.7%, respectively. The T2–FLAIR mismatch sign may be an easy to use and helpful tool in recognizing IDH mutant patients, particularly if formal IDH testing is not available. We suggest that the adoption of a protocol based on imaging and histological data for optimal glioma characterization could be very helpful. |
format | Online Article Text |
id | pubmed-7699466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76994662020-11-29 The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas Kapsalaki, Eftychia Z. Brotis, Alexandros G. Tsikrika, Alexandra Tzerefos, Christos Paschalis, Thanos Dardiotis, Efthymios Fountas, Konstantinos N. Brain Sci Article Our study evaluated the role of the T2–fluid-attenuated inversion recovery (FLAIR) mismatch sign in detecting isocitrate dehydrogenase (IDH) mutations based on a mixed sample of 24 patients with low- and high- grade gliomas. The association between the two was realized using univariate and multivariate logistic regression analysis. There was a substantial agreement between the two raters for the detection of the T2–FLAIR mismatch sign (Cohen’s kappa coefficient was 0.647). The T2–FLAIR mismatch sign when co-registered with the degree of tumor homogeneity were significant predictors of the IDH status (OR 29.642; 95% CI 1.73–509.15, p = 0.019). The probability of being IDH mutant in the presence of T2–FLAIR mismatch sign was as high as 92.9% (95% CI 63–99%). The sensitivity and specificity of T2–FLAIR mismatch sign in the detection of the IDH mutation was 88.9% and 86.7%, respectively. The T2–FLAIR mismatch sign may be an easy to use and helpful tool in recognizing IDH mutant patients, particularly if formal IDH testing is not available. We suggest that the adoption of a protocol based on imaging and histological data for optimal glioma characterization could be very helpful. MDPI 2020-11-19 /pmc/articles/PMC7699466/ /pubmed/33228171 http://dx.doi.org/10.3390/brainsci10110874 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kapsalaki, Eftychia Z. Brotis, Alexandros G. Tsikrika, Alexandra Tzerefos, Christos Paschalis, Thanos Dardiotis, Efthymios Fountas, Konstantinos N. The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas |
title | The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas |
title_full | The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas |
title_fullStr | The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas |
title_full_unstemmed | The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas |
title_short | The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas |
title_sort | role of the t2–flair mismatch sign as an imaging marker of idh status in a mixed population of low- and high-grade gliomas |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699466/ https://www.ncbi.nlm.nih.gov/pubmed/33228171 http://dx.doi.org/10.3390/brainsci10110874 |
work_keys_str_mv | AT kapsalakieftychiaz theroleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT brotisalexandrosg theroleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT tsikrikaalexandra theroleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT tzerefoschristos theroleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT paschalisthanos theroleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT dardiotisefthymios theroleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT fountaskonstantinosn theroleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT kapsalakieftychiaz roleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT brotisalexandrosg roleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT tsikrikaalexandra roleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT tzerefoschristos roleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT paschalisthanos roleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT dardiotisefthymios roleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas AT fountaskonstantinosn roleofthet2flairmismatchsignasanimagingmarkerofidhstatusinamixedpopulationoflowandhighgradegliomas |